REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
44,604,522
Share change
-302,491
Total reported value
$6,583,007,717
Put/Call ratio
36%
Price per share
$147.54
Number of holders
381
Value change
-$39,413,856
Number of buys
193
Number of sells
167

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2020

As of 30 Sep 2020, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 381 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,604,522 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., Select Equity Group, L.P., Conestoga Capital Advisors, LLC, FRED ALGER MANAGEMENT, LLC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., 12 West Capital Management LP, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 383 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.